Summarizing, we prove that telomerase re-activation based on a mutant TERT promoter sequence in BRAFV600E-mutant glioma is driven by oncogenic BRAF signaling predominantly via downstream activation of ETS-factors. This evidence concerns the gene TERT and central nervous system cancer.